Miri Wernli
President chez MIND MEDICINE (MINDMED) INC.
Fortune : 767 163 $ au 31/03/2024
Profil
Miri Halperin Wernli is the founder of Melodiol Global Health Ltd., which was founded in 2015.
She held the title of Group CEO, Managing Director & Executive Director at the company.
Currently, Dr. Wernli is the Executive President at Mind Medicine (MindMed), Inc., starting in 2020.
In her former position, she was the Vice President at Actelion Pharmaceuticals US, Inc. from 2007 to 2016.
Dr. Wernli has an MBA from Stanford University and a doctorate from the University of Geneva.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/02/2024 | 81 353 ( 0,12% ) | 764 718 $ | 31/03/2024 | |
| 29/03/2023 | 750 000 ( 0,18% ) | 2 445 $ | 31/03/2024 |
Postes actifs de Miri Wernli
| Sociétés | Poste | Début |
|---|---|---|
| MIND MEDICINE (MINDMED) INC. | President | 01/02/2021 |
Anciens postes connus de Miri Wernli
| Sociétés | Poste | Fin |
|---|---|---|
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2016 |
| MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 15/08/2020 |
Formation de Miri Wernli
| Stanford University | Masters Business Admin |
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
| MIND MEDICINE (MINDMED) INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
